Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases

Por Federica Ungaro, Federica Rubbino, Silvio Danese, Silvio Danese, Silvia D’Alessio
Publicado em 2017-10-01

Adaptive Designs: Lessons for Inflammatory Bowel Disease Trials

Por Ferdinando D'Amico, Silvio Danese, Laurent Peyrin-Biroulet
Publicado em 2020-07-01

A snapshot of the ongoing clinical research on COVID-19 [version 1; peer review: 2 approved]

Por Daniele Piovani, Claudia Pansieri, Laurent Peyrin-Biroulet, Silvio Danese, Stefanos Bonovas
Publicado em 2020-05-01

Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience

Por Ferdinando D’Amico, Tommaso Lorenzo Parigi, Gionata Fiorino, Laurent Peyrin-Biroulet, Silvio Danese
Publicado em 2019-05-01

Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis

Por Virginia Solitano, Ferdinando D’Amico, Gionata Fiorino, Kristine Paridaens, Laurent Peyrin-Biroulet, Silvio Danese
Publicado em 2020-09-01

Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor

Por Raffaella Maria Gadaleta, Oihane Garcia-Irigoyen, Marica Cariello, Natasha Scialpi, Claudia Peres, Stefania Vetrano, Gionatha Fiorino, Silvio Danese, Brian Ko, Jian Luo, Emanuele Porru, Aldo Roda, Carlo Sabbà, Antonio Moschetta
Publicado em 2020-04-01

mTOR-Dependent Stimulation of <i>IL20RA</i> Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn’s Disease

Por Federica Ungaro, Valentina Garlatti, Luca Massimino, Antonino Spinelli, Michele Carvello, Matteo Sacchi, Salvatore Spanò, Gaia Colasante, Nicholas Valassina, Stefania Vetrano, Alberto Malesci, Laurent Peyrin-Biroulet, Silvio Danese, Silvia D’Alessio
Publicado em 2019-08-01

Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy

Por Maurizio Cecconi, Daniele Piovani, Enrico Brunetta, Alessio Aghemo, Massimiliano Greco, Michele Ciccarelli, Claudio Angelini, Antonio Voza, Paolo Omodei, Edoardo Vespa, Nicola Pugliese, Tommaso Lorenzo Parigi, Marco Folci, Silvio Danese, Stefanos Bonovas
Publicado em 2020-05-01

Composite outcomes in observational studies of Crohn’s disease: a systematic review and meta-analysis

Por Fernando Magro, Catarina Sottomayor, Catarina Alves, Mafalda Santiago, Paula Ministro, Paula Lago, Luís Correia, Raquel Gonçalves, Diana Carvalho, Francisco Portela, Cláudia Camila Dias, Axel Dignass, Silvio Danese, Laurent Peyrin-Biroulet, Maria Manuela Estevinho, Paula Leão Moreira
Publicado em 2022-05-01

Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters

Por HoUng Kim, Rieke Alten, Fraser Cummings, Silvio Danese, Geert D’Haens, Paul Emery, Subrata Ghosh, Cyrielle Gilletta de Saint Joseph, JongHyuk Lee, James O. Lindsay, Elena Nikiphorou, Ben Parker, Stefan Schreiber, Steven Simoens, Rene Westhovens, Ji Hoon Jeong, Laurent Peyrin-Biroulet
Publicado em 2021-01-01

Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study

Por Alfredo Papa, Franco Scaldaferri, Marcello Covino, Antonio Tursi, Federica Furfaro, Giammarco Mocci, Loris Riccardo Lopetuso, Giovanni Maconi, Stefano Bibbò, Marcello Fiorani, Lucrezia Laterza, Irene Mignini, Daniele Napolitano, Laura Parisio, Marco Pizzoferrato, Giuseppe Privitera, Daniela Pugliese, Tommaso Schepis, Elisa Schiavoni, Carlo Romano Settanni, Lorenzo Maria Vetrone, Alessandro Armuzzi, Silvio Danese, Antonio Gasbarrini
Publicado em 2022-04-01